Subtopic Deep Dive
Entamoeba histolytica Cysteine Proteases
Research Guide
What is Entamoeba histolytica Cysteine Proteases?
Cysteine proteases of Entamoeba histolytica are key virulence factors secreted by the parasite to degrade host tissues, cleave mucins, and facilitate invasion during amoebiasis.
These enzymes enable E. histolytica to dissolve the colonic mucus barrier by cleaving MUC2 mucin in its C-terminal domain (Lidell et al., 2006, 254 citations). They contribute to pathogenesis by destroying host extracellular matrix and evading immunity (Que and Reed, 2000, 253 citations). Over 20 studies detail their structure, inhibition, and therapeutic potential.
Why It Matters
Cysteine proteases drive tissue invasion in amoebic liver abscesses and colitis, making them targets for drugs beyond metronidazole resistance issues (Que and Reed, 2000). Allicin from garlic inhibits these proteases and reduces cytopathic effects, suggesting natural compound therapies (Ankri et al., 1997, 173 citations). Targeting them addresses global amoebiasis mortality, with inhibitors blocking mucus degradation and adherence (Lidell et al., 2006; Chadee et al., 1987).
Key Research Challenges
Protease Inhibitor Specificity
Developing selective inhibitors for E. histolytica cysteine proteases without host enzyme toxicity remains difficult. Que and Reed (2000) highlight off-target effects limiting clinical use. Over 250 citations underscore need for parasite-specific structures.
Mucus Degradation Mechanisms
Understanding how proteases precisely cleave MUC2 C-terminal domains to dissolve mucus gel is incomplete. Lidell et al. (2006) identified cleavage sites but in vivo dynamics unclear. This gap hinders barrier restoration strategies.
Drug Resistance Emergence
Metronidazole resistance links to upregulated proteases evading treatment. Petri and Singh (1999) note diagnostic overlaps with non-invasive strains complicating management. Ali and Nozaki (2007) propose sulfur metabolism targets as alternatives.
Essential Papers
Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica.
Kris Chadee, William A. Petri, D J Innes et al. · 1987 · Journal of Clinical Investigation · 291 citations
Establishment of adherence by Entamoeba histolytica is mediated by a 170-kD Gal/GalNAc inhibitable lectin and is required for cytolysis and phagocytosis of mammalian target cells. We studied the bi...
Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica.
William A. Petri, Roger Smith, Paul H. Schlesinger et al. · 1987 · Journal of Clinical Investigation · 280 citations
Entamoeba histolytica adheres to human colonic mucus, colonic epithelial cells, and other target cells via a galactose (Gal) or N-acetyl-D-galactosamine (GalNAc) inhibitable surface lectin. Blockad...
<i>Entamoeba histolytica</i> cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel
Martin E. Lidell, Darcy Moncada, Kris Chadee et al. · 2006 · Proceedings of the National Academy of Sciences · 254 citations
In order for the protozoan parasite Entamoeba histolytica ( E.h. ) to cause invasive intestinal and extraintestinal infection, which leads to significant morbidity and mortality, it must disrupt th...
Cysteine Proteinases and the Pathogenesis of Amebiasis
Xuchu Que, Sharon L. Reed · 2000 · Clinical Microbiology Reviews · 253 citations
Amebiasis is a major cause of morbidity and mortality throughout the tropical world. Entamoeba histolytica is now recognized as a separate species from the morphologically identical E. dispar, whic...
Diagnosis and Management of Amebiasis
William A. Petri, Upinder Singh · 1999 · Clinical Infectious Diseases · 244 citations
s of the annual meeting of the American Society of Tropical Medicine and Hygiene, San Juan, Puerto Rico, 18-22 October1998. North- brook, IL: 1998. 56. Gilman R, Islam M, Paschi S, Goleburn J, Ahma...
Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development
Micaella Kantor, anarella Abrantes, Andrea Estevez et al. · 2018 · Canadian Journal of Gastroenterology and Hepatology · 216 citations
Entamoeba histolytica is the responsible parasite of amoebiasis and remains one of the top three parasitic causes of mortality worldwide. With increased travel and emigration to developed countries...
Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by “Amitochondriate” Protozoan Parasites
Vahab Ali, Tomoyoshi Nozaki · 2007 · Clinical Microbiology Reviews · 202 citations
SUMMARY The “amitochondriate” protozoan parasites of humans Entamoeba histolytica , Giardia intestinalis , and Trichomonas vaginalis share many biochemical features, e.g., energy and amino acid met...
Reading Guide
Foundational Papers
Start with Que and Reed (2000, 253 citations) for pathogenesis overview, then Lidell et al. (2006, 254 citations) for mucin cleavage mechanism, and Chadee et al. (1987, 291 citations) for adherence context.
Recent Advances
Kantor et al. (2018, 216 citations) updates clinical manifestations; Ali and Nozaki (2007, 202 citations) explores sulfur metabolism targets.
Core Methods
Mucin gel dissolution assays (Lidell 2006); allicin inhibition of cytopathic effects (Ankri 1997); lectin adherence blockade (Petri 1987).
How PapersFlow Helps You Research Entamoeba histolytica Cysteine Proteases
Discover & Search
Research Agent uses searchPapers and exaSearch to find 250+ papers on 'Entamoeba histolytica cysteine protease inhibitors', then citationGraph on Que and Reed (2000) reveals 253 citing works including Lidell et al. (2006). findSimilarPapers expands to allicin inhibition studies like Ankri et al. (1997).
Analyze & Verify
Analysis Agent applies readPaperContent to extract protease cleavage sites from Lidell et al. (2006), verifies claims with CoVe against Chadee et al. (1987), and runs PythonAnalysis with pandas to quantify citation impacts across 291-cited adherence lectin papers. GRADE grading scores evidence strength for inhibitor efficacy.
Synthesize & Write
Synthesis Agent detects gaps in protease-mucin interaction data post-2006, flags contradictions between in vitro allicin effects (Ankri et al., 1997) and clinical trials. Writing Agent uses latexEditText for mucin cleavage diagrams, latexSyncCitations for Que/2000 refs, and latexCompile for grant proposals.
Use Cases
"Analyze cysteine protease expression levels across E. histolytica strains from 10 papers"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Que 2000, Lidell 2006) → runPythonAnalysis (pandas meta-analysis of expression data) → CSV export of quantified virulence correlations.
"Draft LaTeX review on protease inhibitors for amoebiasis treatment"
Synthesis Agent → gap detection → Writing Agent → latexEditText (structure sections) → latexSyncCitations (Ankri 1997, Ali 2007) → latexCompile → PDF with mucus degradation figure.
"Find GitHub repos modeling E. histolytica protease kinetics"
Research Agent → citationGraph (Que 2000) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for inhibitor simulation.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'cysteine proteases amoebiasis', structures report with GRADE-scored sections on pathogenesis (Que 2000 first). DeepScan applies 7-step CoVe to verify mucin cleavage claims from Lidell (2006) against Chadee (1987). Theorizer generates hypotheses on allicin-protease synergies (Ankri 1997) for novel inhibitor design.
Frequently Asked Questions
What defines Entamoeba histolytica cysteine proteases?
They are secreted cathepsin-like enzymes degrading host mucins and tissues for invasion (Que and Reed, 2000).
What methods study these proteases?
In vitro assays measure mucin cleavage (Lidell et al., 2006); allicin inhibition tests cytopathic effects (Ankri et al., 1997).
What are key papers?
Que and Reed (2000, 253 citations) reviews pathogenesis; Lidell et al. (2006, 254 citations) details MUC2 cleavage.
What open problems exist?
Selective inhibitors avoiding host toxicity and in vivo mucus dynamics need resolution (Que and Reed, 2000).
Research Amoebic Infections and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Entamoeba histolytica Cysteine Proteases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Amoebic Infections and Treatments Research Guide